Impact News +++ Corporate News: Heidelberg Pharma AG (EQS) +++ HEIDELBERG PHARMA Aktie -5,66%

OPTHEA ADR Aktie

>OPTHEA ADR Performance

1 Woche: 0%

1 Monat: 0%

3 Monate: 0%

6 Monate: 0%

1 Jahr: -1,3%

laufendes Jahr: -18,5%

>OPTHEA ADR Aktie

Name:

OPTHEA LTD (SP.ADR/8)

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US68386J2087 / A2QEW7

Symbol/ Ticker:

UKJ2 (Frankfurt) / OPT (NASDAQ)

Kürzel:

FRA:UKJ2, ETR:UKJ2, UKJ2:GR, NASDAQ:OPT

Index:

Webseite:

https://opthea.com/

Profil:

Opthea Ltd Sponsored ADR is an American Depositary..
>Volltext..

Marktkapitalisierung:

419.2 Mio. EUR

Unternehmenswert:

588.32 Mio. EUR

Umsatz:

0.02 Mio. EUR

EBITDA:

Nettogewinn:

-138.24 Mio. EUR

Gewinn je Aktie:

-0.91 EUR

Schulden:

210.38 Mio. EUR

Liquide Mittel:

41.26 Mio. EUR

Operativer Cashflow:

-135.17 Mio. EUR

Bargeldquote:

0.19

Umsatzwachstum:

-80.09%

Gewinnwachstum:

26.54%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

OPTHEA ADR, OPTHEA

Letzte Datenerhebung:

17.12.25

>OPTHEA ADR Kennzahlen

Aktien/ Unternehmen:

Aktien: 171 Mio. St.

Frei handelbar: -

Leerverk. Aktien: -

Rückkaufquote: -7.09%

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Neutral

Kursziel: -

Bewertung:

KGV: -

KGV lG: -

KUV: 346.04

KBV: -

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -651570.83%

Operative Marge: -624607.57%

Managementeffizenz:

Gesamtkaprendite: -132.17%

Eigenkaprendite: -

>OPTHEA ADR Peer Group

Es sind 599 Aktien bekannt.

>OPTHEA ADR Chart & Kurs - NASDAQ

>OPTHEA ADR News

19.08.25 - 01:03	Opthea Provides Corporate Update (GlobeNewswire EN)
	Successful DFA settlement reached...

06.05.25 - 05:01	Hedge Fund Regal Says Biotech Blowup Triggered No Redemptions (Bloomberg)
	Regal Partners Ltd. co-founder Phil King says he's learned from mistakes made in the firm's Opthea Ltd. investment that went awry....

10.04.25 - 05:30	Thursday′s HotCopper Trends: Sayona merger, Opthea slashes jobs \| April 10, 2025 (Market Herald)
	The ASX has been up, charging 4.7% higher at around 7,720 points…...

10.04.25 - 03:31	Opthea, with shares still suspended, cuts workforce by 65% after drug trials cancelled (Market Herald)
	Troubled biotech stock Opthea (ASX:OPT), still in the process of crisis talks…...

31.03.25 - 08:15	Opthea announces decision to discontinue wet AMD trials (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

28.03.25 - 07:30	HotCopper Highlights for Week 13 – Opthea, Reject Shop, Bellevue & more! (Market Herald)
	Good Afternoon and welcome to HotCopper Highlights, I'm Jonathon Davidson. This is…...

25.03.25 - 02:24	Amid fears of collapse, whats happening with Opthea ASX shares today? (Fool)
	A failed clinical trial has rattled investors. The post Amid fears of collapse, what's happening with Opthea ASX shares today? appeared first on The Motley Fool Australia....

24.03.25 - 05:54	Opthea raises solvency concerns after phase 3 trial fails (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

24.03.25 - 05:03	Opthea Announces COAST Phase 3 Trial Topline Results (GlobeNewswire EN)
	COAST Phase 3 trial failed to meet primary endpoint of mean change in BCVA from baseline to week 52...

24.03.25 - 03:24	Opthea’s Phase 3 trial results fail to help patients, future of company at risk (Market Herald)
	It mightn't be too surprising Opthea (ASX:OPT) applied for a voluntary suspension…...

24.03.25 - 03:24	Monday′s HotCopper Trends: Opthea strife, Errawarra jumps on acquisitions, Memphasys best-in-class trial results \| March 21, 2025 (Market Herald)
	The ASX has been trading flat at around 7,928 points. Discretionary has…...

17.03.25 - 15:42	XFRA : UKJ2: Aussetzung/Suspension (XETRA)
	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL OPTHEA LTD (SP.ADR/8) UKJ2 US68386J2087 BAW/UFN...

17.03.25 - 15:39	XFRA : INSTRUMENT_SUSPENSION - US68386J2087 (XETRA)
	Instrument ID [5170289] (UKJ2 - US68386J2087) suspended...

03.03.25 - 13:03	Opthea Announces Phase 2b Wet AMD Publication (GlobeNewswire EN)
	Baseline angiographic lesion characteristics predictive of clinical response...

28.02.25 - 13:03	Opthea Reports Half Year Results and Business Updates (GlobeNewswire EN)
	Cash and cash equivalents of $131.9M as of December 31, 2024...

07.02.25 - 13:03

Opthea to Present at Oppenheimer Healthcare Conference (GlobeNewswire EN)

MELBOURNE, Australia and PRINCETON, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that Frederic Guerard, PharmD, Chief Executive Officer, will present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference and host one-one-one meetings....

06.02.25 - 13:03

Opthea Wet AMD Data Featured at Macula Society Meeting (GlobeNewswire EN)

MELBOURNE, Australia, and PRINCETON, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that sozinibercept will be highlighted during an oral presentation at the Macula Society 48th Annual Meeting being held February 12-15, 2025 in Charlotte Harbor, Florida. The Macula Society is a forum for new research in retinal vascular and macular diseases....

08.01.25 - 13:03	Opthea to Host Investor Days in New York and Australia (GlobeNewswire EN)
	Updates on commercial insights and readiness plans for sozinibercept in wet AMD...

07.01.25 - 04:12	Biotech smallcap Opthea eyes 5% jump as key drug of interest validated in paper (Market Herald)
	Dual ASX and NASDAQ listed Opthea Ltd (ASX:OPT) has jumped 4.5% to…...

07.01.25 - 03:24	Why Capricorn Metals, IDP Education, Life360, and Opthea shares are storming higher (Fool)
	These shares are having a good session on Tuesday. But why? Let's find out. The post Why Capricorn Metals, IDP Education, Life360, and Opthea shares are storming higher appeared first on The Motley Fool Australia....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Der Mensch ward zum Tun und nicht zum Vernünfteln erschaffen. Aber eben deswegen, weil er nicht dazu erschaffen ward, hängt er diesem mehr als jenem nach. - Gotthold Ephraim Lessing

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram